We are in position to produce all Iboga and Voacanga products from our raw materials, from the powder up to the HCL.
With the availability of raw materials, and a functional laboratory near by our farms we can offer European standard products at competitive prices.
2. CONTENTS
01 What we do and stand for. Our targets. Our goals
ABOUT THE COMPANY
02 Our farms. Cultivation of Iboga in African. Processing of Iboga
TABERNANTHE IBOGA
03 VOACANGA AFRICANA
Processing. Preparation of ibogaine from Voacanga Africana
04 TREATMENT OF COVID-19 NEUROLOGICAL DAMAGES
Ibogaine releases nerve growth factor (NGF) which help fights against Neuro viruses
3. BULK AFRICAN TRADE
Our Operations. Our Activities. Our targets and what we do
About the Company
4. A B C
About us
Bulk African Trade is a limited
liability company who are into
farming and processing of
African traditional herbal plants
into finished and semi finished
products. BAT as the short name
for Bulk African Trade also sell
raw materials of these medicinal
trees of Africa worldwide. BAT is
located at the Tropical zone of
Ghana, West Africa, in a small
town called Akim Oda.
Our team
Our team comprises of
Ghanaian farm managers,
medicinal plant specialists and
laboratory chemists. Our
farms make it more easier to
get the raw materials to
process components of the
iboga plant. We have been
operating since 2016 as
exporter of the iboga root bark
and the root bark powder.
Our target
Our aim is to be the world
leading iboga and Voacanga
suppliers and for that matter,
we have put measures in
place to increase our total
number of plants. Currently we
have a total of 25,000 iboga
plants among which 5,000
have been planted on the field
and 20,000 in the nursery
bags. Our estimated current
production is between 10kg of
iboga products from Iboga,
and 50kg of Voa*Ibogaine per
a year.
5. 74%
38%
Statistics on Addiction of One of our target Market (America)
Almost 74% of adults suffering from a substance use
disorder in 2017 struggled with an alcohol use disorder
According to the National Survey on Drug Use and Health (NSDUH), 19.7
million American adults (aged 12 and older) battled a substance use disorder
in 2017.
About 38% of adults in 2017 battled an illicit drug
use disorder
In 2017, 8.5 million American adults suffered from both a mental health disorder and a substance use disorder, or co-
occurring disorders.1
Drug abuse and addiction cost American society more than $740 billion annually in lost workplace productivity,
healthcare expenses, and crime-related costs
6. In order to be of economical importance we
started to look out for way which we will help
solve this global issue which is costing the world
millions to cure. We realized we already have the
potential in Africa. With mention of the plants like
Voacanga Africana and Tabernanthe Iboga which
are having some psychedelic properties when
used carefully.
We started with the production of TA, PTA*hcl
and Ibogaine*hcl in Germany since 2017. In
December 2019, we hired the service of a
chemist from Germany and set up a fully
functional laboratory to process our Raw
materials (Iboga Tabernanthe and Voacanga
Africana) directly in Ghana at the place of origin,
to the final products
TA, PTA*hcl and Ibogaine HCL.
Ibogaine*Hcl PTA*Hcl
7. Our farms and Activities on
Secrets of African Traditional Herbs
Tabernanthe Iboga
8. A
We Harvest
After years of growing these plants, we
harvest them for our chemists to work on
them for further processes.
We Process to Finished Products
With the services of our chemists are able to
processed them into root bark chips, root
bark powder, Iboga TA, Iboga PTA and
Ibogaine*Hcl.
We Plant
To ensure we get the cheapest source of
raw materials in order to be competitive, we
plant by ourselves. And in situations where
outsourcing is the cheapest and smartest
way, we adopt this approach to get enough
supplies to be at a competitive side.
We Grow
We have employed and trained our local
farmers on how best to ensure that our
plants are in good condition in order to feed
us with the necessary raw materials we will
need to meet our demand.
B
C
D
Stages of Our Activities
16. 5 6
Ibogaine HCL
Ibogaine HCL is the third grade of Ibogaine
and is most often used as addiction therapy.
Ibogaine HCL contains approximately 90-99
percent pure Ibogaine.
Iboga PTA*HCL
Iboga Purified total extracts (PTA) takes
total alkaloid extracts (TA) through another
level of processing.. The PTA contains more
than 80% Ibogaine and the other two
alkaloids are Ibogaline and Ibogamine at
around 20%. These two other alkaloids have
similar effects as Ibogaine and are additive
in the overall psycho-activity.
Our Iboga Products
17. Iboga alkaloid spectrum in 2 Years
old Iboga plants.
Results comparison of PTA*hcl and
ibogaine*hcl
22. TREATMENT OF COVID-19 NEUROLOGICAL DAMAGES
In humans, viral infections of the respiratory tract are a leading cause of morbidity and mortality worldwide.
Several recognized respiratory viral agents have a neuroinvasive capacity since they can spread from the
respiratory tract to the central nervous system (CNS). Once there, infection of CNS cells (neurotropism)
could lead to human health problems, such as encephalitis and long-term neurological diseases. Among
the various respiratory viruses, coronaviruses are important pathogens of humans and animals. Human
Coronaviruses (HCoV) usually infect the upper respiratory tract, where they are mainly associated with
common colds. However, in more vulnerable populations, such as newborns, infants, the elderly, and
immune-compromised individuals, they can also affect the lower respiratory tract, leading to pneumonia,
exacerbations of asthma, respiratory distress syndrome, or even severe acute respiratory syndrome
(SARS). The respiratory involvement of HCoV has been clearly established since the 1960s. In addition,
for almost three decades now, the scientific literature has also demonstrated that HCoV are neuroinvasive
and neurotropic and could induce an overactivation of the immune system, in part by participating in the
activation of autoreactive immune cells that could be associated with autoimmunity in susceptible
individuals.
23. Furthermore, it was shown that in the murine CNS, neurons are the main target of infection,
which causes these essential cells to undergo degeneration and eventually die by some form of
programmed cell death after virus infection. Moreover, it appears that the viral surface glycoprotein
(S) represents an important factor in the neurodegenerative process. Given all these properties, it
has been suggested that these recognized human respiratory pathogens could be associated with
the triggering or the exacerbation of neurological diseases for which the etiology remains unknown
or poorly understood (Desforges et al,2014).
According to Soledad M. et al, ibogaine administration simultaneously alters the expression of
GDNF, BDNF, and NGF transcripts in rat brain regions related to the dopamine neurotransmission in
a dose- and time-dependent manner. Their results add relevant information concerning specific brain
areas involved in the increment of GDNF levels (VTA) as a putative mechanism of action underlying
the anti-addictive effect of ibogaine. Ibogaine has a neurotrophic factor and neuropeptide primarily
involved in the regulation of growth, maintenance, proliferation, and survival of certain target
neurons. It is perhaps the prototypical growth factor, in that it was one of the first to be described.
Since it was first isolated by Nobel Laureates Rita Levi-Montalcini and Stanley Cohen in 1956,
numerous biological processes involving NGF have been identified, two of them being the survival of
pancreatic beta cells and the regulation of the immune system.
24. Visit our Website
http://www.ibogaceremony.com/
For more info
Email : madoe@bulkafricantrade.de
Author
Bismark Dadzie
08.04.2020
CONCLUSION
We are in position to produce all Iboga and Voacanga products from our raw materials, from the powder up to the HCL.
With the availability of raw materials, and a functional laboratory near by our farms we can offer European standard
products at competitive prices.
25. REFERENCEs
• “Statistics on Drug Addiction”. https://americanaddictioncenters.org/rehab-guide/addiction-statistics. Accessed on 8th April
2020
• Wells, G. B., Lopez, M. C., and Tanaka, J. C. (1999). The effects of ibogaine on dopamine and serotonin transport in rat brain
synaptosomes. Brain Res. Bull. 48, 641–647.
• Desforges, M., Le Coupanec, A., Brison, E., Meessen-Pinard, M., & Talbot, P. J. (2014). Neuroinvasive and neurotropic
human respiratory coronaviruses: potential neurovirulent agents in humans. Advances in experimental medicine and biology,
807, 75–96. https://doi.org/10.1007/978-81-322-1777-0_6
• “Nerve growth Factor”.https://en.wikipedia.org/wiki/Nerve_growth_factor. Accessed on 8th April 2020
